AK 0406
Alternative Names: AK-0406Latest Information Update: 17 May 2024
At a glance
- Originator Ark Biosciences
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Influenza virus infections
Most Recent Events
- 25 Apr 2024 Preclinical trials in Influenza virus infections in China (unspecified route) prior to April 2024 (Ark Biosciences pipeline April 2024)